Azelastine is applied directly to the nasal mucosa, providing rapid local relief with minimal systemic absorption. Oral antihistamines work throughout the body and may cause drowsiness, especially first-generation agents.
Yes, azelastine can be used with a deviated septum, but avoid spraying directly onto the septum to reduce irritation. If severe pain or bleeding occurs, contact a clinician.
With the recommended dosing of one spray per nostril twice daily, a 10 ml bottle generally lasts about four weeks.
Yes, azelastine nasal spray is a prescription-only medicine (POM) regulated by the MHRA.
It can be used in combination, but they should be administered at different times (e.g., one in the morning, the other in the evening) to minimise local irritation.
Some users report temporary reduction in smell shortly after dosing, which usually resolves after continued use or when the medication is stopped.
Azelastine is approved for children aged 6 years and older. For teenagers, the same dosing regimen as adults is recommended unless a clinician advises otherwise.
Yes, but keep the bottle in its original packaging, carry it in hand luggage, and be prepared to show the prescription if asked at security.
No specific dietary restrictions are known for azelastine. Maintaining a balanced diet is advisable for overall allergy management.
The bitter taste is a common, mild side effect. Avoid swallowing the spray solution and allow it to spread across the nasal mucosa. If the taste persists or is bothersome, discuss alternative formulations with your healthcare provider.
This article covers Azelastine, available as a generic medication and marketed under brand names such as Astepro and Astelin. Azelastine is classified as an allergy-relief (antihistamine) agent and is supplied as a 10 ml intranasal sprayer for the treatment of allergic rhinitis and related nasal symptoms. In the United Kingdom it is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Azelastine is a second-generation antihistamine that blocks the H₁ histamine receptors located on nasal mucosal cells. By preventing histamine from binding to these receptors, azelastine reduces the inflammation, itching, sneezing, and runny nose that occur during an allergic response.
These indications are approved by the MHRA for use in adults and children aged 6 years and older. Azelastine relieves nasal congestion, sneezing, itching, and rhinorrhoea associated with these conditions.
Patients should always inform their healthcare provider of all medicines, supplements, and herbal products they are taking.
Routine laboratory monitoring is not required for azelastine. However, patients should schedule a follow-up visit after 2-4 weeks of therapy to assess symptom control and any local adverse effects. Persistent nosebleeds, severe irritation, or lack of improvement warrant medical review.
This article provides educational information about Azelastine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
